Repository of Research and Investigative Information

Repository of Research and Investigative Information

Torbat Heydariyeh University of Medical Sciences

Brain metastases from hepatocellular carcinoma: A rare case report

(2020) Brain metastases from hepatocellular carcinoma: A rare case report. Acta Medica Iranica. pp. 47-49. ISSN 00446025

[img] Text
7998-Article Text-15116-1-10-20200616 (1).pdf

Download (374kB)

Official URL:


Intrahepatic lesions of hepatocellular carcinoma (HCC) have been controlled by significant advances in treatment, including chemotherapy, surgery, and ablative therapy. Consequently, the number of patients with extrahepatic metastatic lesions has increased, including lung, regional lymph nodes, peritoneum, and adrenal glands, but rarely to the brain. The prognosis of brain metastasis remains poor, with approximately <1 y of survival from the time of diagnosis. Although no guidelines for the brain metastasis of HCC have been developed to date due to the lack of the experiences and pieces of evidence, a molecularly targeted drug, sorafenib, have been used to treat extrahepatic lesions and shown the prolonged survival time. Therefore, the development of standard therapy for brain metastasis following the early diagnosis is essential by accumulating the information of clinical courses and pieces of evidence. © 2020, Medical Sciences University of Teheran. All rights reserved.

Item Type: Article
Keywords: Brain metastasis; Hepatocellular carcinoma; Prognosis
Page Range: pp. 47-49
Journal or Publication Title: Acta Medica Iranica
Journal Index: Scopus
Volume: 58
Number: 1
Publisher: Medical Sciences University of Teheran
ISSN: 00446025
Depositing User: دکتر محبوبه عبداللهی

Actions (login required)

View Item View Item